Poltreg S.A. (WSE:PTG)
Poland · Delayed Price · Currency is PLN 19.95
+0.30 (1.53%)
Nov 4, 2026, 1:53 PM CET
Poltreg Revenue
Revenue (ttm)
240.00K
Revenue Growth
-4.00%
P/S Ratio
484.41
Revenue / Employee
7.06K
Employees
34
Market Cap
118.03M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 350.00K | -1.05M | -74.98% |
| Dec 31, 2023 | 1.40M | 400.00K | 40.04% |
| Dec 31, 2022 | 999.00K | -100.00K | -9.10% |
| Dec 31, 2021 | 1.10M | 399.00K | 57.00% |
| Dec 31, 2020 | 700.00K | 200.00K | 40.00% |
| Dec 31, 2019 | 500.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 257.23M |
| Ryvu Therapeutics | 83.94M |
| Synthaverse | 48.76M |
| Mabion | 17.61M |
| Read-Gene | 16.66M |
| Molecure | 6.52M |
| Urteste | 2.77M |
| NanoGroup | 2.37M |
Poltreg News
- 7 weeks ago - Poltreg Quarterly report: Q2 2026 - Filings
- 5 months ago - Poltreg Quarterly report: Q1 2026 - Filings
- 6 months ago - Poltreg Annual report: Q4 2025 - Filings
- 9 months ago - Poltreg Slides: Investor presentation - Filings
- 10 months ago - Poltreg Slides: Investor presentation - Filings
- 11 months ago - Poltreg Quarterly report: Q3 2025 - Filings